BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 15, 2000
View Archived Issues
Full-year summary: SmithKline Beecham files for FDA approval of three products during 1999
Read More
Amrad accelerates development of lead compounds during 1999
Read More
Additional mechanism of action revealed for Neovastat
Read More
3-D and Boehringer Ingelheim enter R&D collaboration
Read More
SangStat presents new antiinflammatory candidate RDP-58
Read More
Orphan Medical's Busulfex approved in Israel
Read More
Medarex and Regeneron form human antibody drug collaboration
Read More
NIH advisory committee approves phase III protocol for Introgen's p53 gene therapy
Read More
Collgard receives orphan drug status for scleroderma therapy
Read More
Baxter exercises option in cardiovascular collaboration with Sangamo
Read More
Small-molecule integrin antagonists under study at Merck & Co.
Read More
Novel migraine therapies from Lilly interact with 5-ht1f receptor
Read More
Broad-spectrum antibiotics useful for infections due to resistant staphylococci, streptococci
Read More
3M's new immunomodulators induce TNF-alpha, IFN-alpha biosynthesis, inhibit Th2 immune response
Read More
CCR5 receptor-modulating anilides claimed by SmithKline in recent patent
Read More
Continued focus at Lilly on compounds potentiating glutamate receptor function
Read More
4-Aminopyridine derivative LI-8 may be clinically useful for antagonizing residual NM block
Read More
Swedish authorities issue first approval for next-generation PPI
Read More
Sea whip metabolite with potential for the treatment of tuberculosis
Read More
Sigma-Tau will develop Zadaxin throughout Europe for HCV and cancer
Read More
AstraZeneca's P2T antagonist AR-C69931MX beneficial and safe for acute coronary syndromes
Read More
Platelet antiaggregatory activity of antidepressants
Read More
NicOx begins clinical trials of HCT-1026 for dermatology indications
Read More
Clinical trials of (S)-doxazosin in BPH commenced
Read More
ACC news: preliminary clinical results presented for Chiron's rFGF-2 angiogenesis therapy
Read More
Novo Nordisk receives approval in Japan for NovoSeven
Read More
CholestaGel safe and effective as monotherapy in patients with type IIa hypercholesterolemia
Read More